For those with papillary RCC, Fitzgerald et al showed that 32 patients treated with the combination of cabozantinib (Cabometyx) and nivolumab (Opdivo) had an overall response rate (ORR) of 47% and a ...
Karsen Kitchen, 21, was one of six crew members for Blue Origin's New Shepard 26 flight, which launched around 9 a.m. The flight took just over 10 minutes launching the crew at a maximum velocity ...